Gene editing may change the treatment landscape of hypercholesterolaemia Presented ByDr Andrew Bellinger, Verve Therapeutics, USA TrialPhase 1, heart-1 ConferenceAHA 2023 TypePeer-reviewed article 29 January 2024 14:35